Subsaturated transdermal delivery device

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/159

A61K 9/70 (2006.01) A61K 31/465 (2006.01)

Patent

CA 1338700

Subsaturated, rate controlled delivery devices (I) for delivering an agent (5). The initial equilibrated concentration of the agent in the agent reservoir (3) and the adhesive (5) is below saturation. The initial loading of the agent in reservoir (3) is sufficient to prevent the activity of the agent in the reservoir (3) from decreasing by more than about 75% and preferably no more than about 25% during the predetermined period of administration. The thicknesses of the adhesive (5), rate controlling membrane (4) and reservoir (3) layers are selected so that at least 50% and, preferably at least 75% of the initial equilibrated agent loading is in the reservoir layer (3). The devices (1) are usable to deliver agents which are liquid at body temperatures such as benztropine, secoverine, nicotine, arecoline, polyethylene glycol monolaurate, glycerol monolaurate, glycerol monooleate and ethanol, for example.

602649

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Subsaturated transdermal delivery device does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Subsaturated transdermal delivery device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Subsaturated transdermal delivery device will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1177610

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.